Abstract
SELEX (systematic evolution of ligands by exponential enrichment) is an in vitro iterative selection procedure used to identify oligonucleotides (aptamers) with desired protein or complex targets, such as cells. Given that binding of aptamer depends on their target conformation which is in turn conditioned by the target's environment, and obviously in vitro SELEX is no guarantee for the selected aptamers recognizing their cognate target in vivo, we seek to develop tumor-targeting aptamers through a novel in vivo application of SELEX.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
